MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 198 filers reported holding MYRIAD GENETICS INC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,160,000 | -33.8% | 742,138 | -37.0% | 0.51% | -37.3% |
| Q2 2022 | $21,391,000 | -54.9% | 1,177,250 | -37.5% | 0.82% | -54.0% |
| Q1 2022 | $47,435,000 | -15.2% | 1,882,357 | -7.1% | 1.77% | -6.8% |
| Q4 2021 | $55,909,000 | -39.7% | 2,025,681 | -29.5% | 1.90% | -30.2% |
| Q3 2021 | $92,767,000 | -1.8% | 2,872,918 | -7.0% | 2.73% | -7.9% |
| Q2 2021 | $94,466,000 | +14.1% | 3,089,152 | +13.6% | 2.96% | +17.1% |
| Q1 2021 | $82,782,000 | +5881.4% | 2,718,623 | +6614.1% | 2.53% | +10012.0% |
| Q1 2014 | $1,384,000 | -83.8% | 40,491 | -90.0% | 0.02% | -85.4% |
| Q4 2013 | $8,520,000 | +140.0% | 406,103 | +19.0% | 0.17% | +101.2% |
| Q3 2013 | $3,550,000 | -59.7% | 341,376 | -33.8% | 0.08% | -70.9% |
| Q1 2013 | $8,804,000 | – | 515,468 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $98,875,000 | 3.47% |
| Tieton Capital Management, LLC | 187,636 | $3,711,000 | 2.72% |
| Glenview Capital Management | 3,682,691 | $72,825,000 | 1.67% |
| Altium Capital Management LP | 218,650 | $4,324,000 | 1.61% |
| S&T BANK/PA | 331,098 | $6,547,000 | 1.18% |
| EARNEST PARTNERS LLC | 6,731,429 | $133,114,000 | 0.92% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 2,078,075 | $41,094,000 | 0.79% |
| SummerHaven Investment Management, LLC | 35,700 | $706,000 | 0.55% |
| AIMZ Investment Advisors, LLC | 42,685 | $844,000 | 0.44% |
| CONTINENTAL ADVISORS LLC | 36,392 | $720,000 | 0.33% |